A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes

被引:69
作者
Jerdi, MC [1 ]
Daali, Y [1 ]
Oestreicher, MK [1 ]
Cherkaoui, S [1 ]
Dayer, P [1 ]
机构
[1] Univ Hosp Geneva, Clin Pharmacol & Toxicol, CH-1211 Geneva 14, Switzerland
关键词
cytochrome P450; cocktail; HPLC; validation;
D O I
10.1016/j.jpba.2004.03.021
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
An efficient, fast and reliable analytical method was developed for the simultaneous evaluation of the activities of five major human drug metabolising cytochrome P450 (1A2, 2C9, 2C19, 2D6 and 3A4) with a cocktail approach including five probe substances, namely caffeine, flurbiprofen, omeprazole, dextromethorphan and midazolam. All substances were administered simultaneously and a single plasma sample was obtained 2 h after the administration. Plasma samples were handled by liquid-liquid extraction and analysed by gradient high performance liquid chromatography (HPLC) coupled to UV and fluorescence detectors. The chromatographic separation was achieved using a Discovery semi-micro HS C18 HPLC column (5 mum particle size, 150 mm x 2.1 mm i.d.) protected by a guard column (5 mum particle size, 20 mm x 2.1 mm i.d.) The mobile phase was constituted of a methanol, acetonitrile and 20 mM ammonium acetate (pH 4.5) with 0.1% triethylamine mixture and was delivered at a flow rate of 0.3 mL min(-1). All substances were separated simultaneously in a single run lasting less than 22 min. The HPLC method was formally validated and showed good performances in terms of linearity, sensitivity, precision and accuracy. Finally, the method was found suitable for the screening of these compounds in plasma samples. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1203 / 1212
页数:10
相关论文
共 27 条
[21]   Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail" [J].
Streetman, DS ;
Bleakley, JF ;
Kim, JS ;
Nafziger, AN ;
Leeder, JS ;
Gaedigk, A ;
Gotschall, R ;
Kearns, GL ;
Bertino, JS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (04) :375-383
[22]   PHARMACOKINETIC COMPARISON OF ORAL AND LOCAL-ACTION TRANSCUTANEOUS FLURBIPROFEN IN HEALTHY-VOLUNTEERS [J].
TABURET, AM ;
SINGLAS, E ;
GLASS, RC ;
THOMAS, F ;
LEUTENEGGER, E .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1995, 20 (02) :101-107
[23]   High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry [J].
Testino, SA ;
Patonay, G .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 30 (05) :1459-1467
[24]  
THUMMEL KE, 1994, J PHARMACOL EXP THER, V271, P549
[25]   Studies of flurbiprofen 4'-hydroxylation - Additional evidence suggesting the sole involvement of cytochrome P450 2C9 [J].
Tracy, TS ;
Marra, C ;
Wrighton, SA ;
Gonzalez, FJ ;
Korzekwa, KR .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (08) :1305-1309
[26]  
Von Moltke LL, 1998, J PHARM PHARMACOL, V50, P997
[27]  
Zhu B, 2001, ACTA PHARMACOL SIN, V22, P634